---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000312"
form_type: "8-K"
ticker: null
cik: "0001629205"
company_name: "Innovation1 Biotech Inc."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T01:57:08.174922+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Innovation1 Biotech appoints Samuel Knipper as CFO and interim CEO

## Summary
- Samuel Knipper, 30, appointed CFO effective Feb 23, 2025; also named interim CEO under Brio agreement.
- Knipper designated by Brio Financial Group; company pays Brio $8,500/month plus expenses for controller and reporting services.
- Appointment lasts approximately 120 days or until close of a SPAC merger or exchange listing, whichever comes first.
- Knipper previously senior associate at Calabrese Consulting and SEC reporting manager at Brio Financial Group.

## SEC filing metadata
- accession: 0001753926-25-000312
- form_type: 8-K
- cik: 0001629205
- company_name: Innovation1 Biotech Inc.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1629205/000175392625000312/0001753926-25-000312-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1629205/000175392625000312/g084715_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000312
- JSON: https://secwatch.observer/filing/0001753926-25-000312.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000312.txt

## Key facts
- Executive change
  Samuel Knipper was appointed as Chief Financial Officer at Innovation1 Biotech Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 23, 2025, Innovation1 Biotech Inc. (the “Company”) appointed Samuel Knipper to serve as chief financial officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1629205/000175392625000312/0001753926-25-000312-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.